Published in J Biol Chem on August 05, 1994
A conserved tissue-specific structure at a human T-cell receptor beta-chain core promoter. Mol Cell Biol (1997) 1.10
A defective Vkappa A2 allele in Navajos which may play a role in increased susceptibility to haemophilus influenzae type b disease. J Clin Invest (1996) 1.03
Efficient transcription of an immunoglobulin kappa promoter requires specific sequence elements overlapping with and downstream of the transcriptional start site. Nucleic Acids Res (1997) 0.81
The POU transcription factor Oct-1 represses virus-induced interferon A gene expression. Mol Cell Biol (2005) 0.81
85-kDa cytosolic phospholipase A2 group IValpha gene promoter polymorphisms in patients with severe asthma: a gene expression and case-control study. Clin Exp Immunol (2007) 0.77
The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus. Nature (1983) 5.76
Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro. Proc Natl Acad Sci U S A (1988) 4.33
Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha. Proc Natl Acad Sci U S A (1991) 3.80
Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters. Nature (1985) 3.45
NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol (1999) 3.42
Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet (2001) 3.27
Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest (1997) 3.22
Contacts between hormone receptor and DNA double helix within a glucocorticoid regulatory element of mouse mammary tumor virus. Proc Natl Acad Sci U S A (1984) 2.64
The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. Proc Natl Acad Sci U S A (1992) 2.56
Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B. Nature (1992) 2.50
Activation of NF-kappa B in vivo is regulated by multiple phosphorylations. EMBO J (1994) 2.31
Glucocorticoid receptors recognize DNA sequences in and around murine mammary tumour virus DNA. EMBO J (1982) 2.21
The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators. Oncogene (1999) 2.15
Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro. Genes Dev (1992) 2.12
NF-kappaB and the innate immune response. Curr Opin Immunol (2000) 2.04
Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo. EMBO J (1996) 1.97
The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B. EMBO J (1993) 1.90
NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes. EMBO J (1999) 1.87
High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood (1996) 1.82
Ubiquitous transcription factor OTF-1 mediates induction of the MMTV promoter through synergistic interaction with hormone receptors. Cell (1991) 1.81
Common structural constituents confer I kappa B activity to NF-kappa B p105 and I kappa B/MAD-3. EMBO J (1993) 1.77
Maintenance of NF-kappa B activity is dependent on protein synthesis and the continuous presence of external stimuli. Mol Cell Biol (1991) 1.74
Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene (1999) 1.71
Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices. Development (2001) 1.69
Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha. Mol Cell Biol (2001) 1.66
The NF-kappa B/Rel and I kappa B gene families: mediators of immune response and inflammation. J Mol Med (Berl) (1996) 1.64
Purified octamer binding transcription factors stimulate RNA polymerase III--mediated transcription of the 7SK RNA gene. Cell (1989) 1.61
Functional interference of Sp1 and NF-kappaB through the same DNA binding site. Mol Cell Biol (1998) 1.60
Fe homeostasis in plant cells: does nicotianamine play multiple roles in the regulation of cytoplasmic Fe concentration? Planta (2001) 1.53
Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood (1999) 1.53
Molecular model of the interaction between the glucocorticoid receptor and the regulatory elements of inducible genes. DNA (1986) 1.53
The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component. J Biol Chem (2000) 1.49
[Diagnosis of endolymphatic hydrops using low frequency modulated distortion product otoacoustic emissions]. HNO (2005) 1.43
High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. Br J Cancer (2007) 1.37
Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation (1999) 1.37
NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors. Oncogene (1993) 1.32
Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia (2000) 1.23
Genetic analysis of two tomato mutants affected in the regulation of iron metabolism. Mol Gen Genet (1996) 1.17
Mechanism of gene regulation by steroid hormones. J Steroid Biochem (1986) 1.14
Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex. Mol Cell Biol (2000) 1.10
Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage. FASEB J (2001) 1.02
Human exposure and internal dose assessments of acrylamide in food. Food Chem Toxicol (2005) 1.01
Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence. EMBO J (1999) 0.96
B-cell receptor- and phorbol ester-induced NF-kappaB and c-Jun N-terminal kinase activation in B cells requires novel protein kinase C's. Mol Cell Biol (2001) 0.96
Signal-dependent degradation of IkappaBalpha is mediated by an inducible destruction box that can be transferred to NF-kappaB, bcl-3 or p53. Nucleic Acids Res (1998) 0.94
Regulation of NF-kappa B activity by I kappa B alpha and I kappa B beta stability. Immunobiology (1997) 0.94
Signal transduction. Docking IkappaB kinases. Nature (1998) 0.94
Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study. In Vitr Mol Toxicol (2000) 0.92
Melatonin reduces UV-induced reactive oxygen species in a dose-dependent manner in IL-3-stimulated leukocytes. J Pineal Res (2001) 0.90
Alternative splicing variants of IkappaB beta establish differential NF-kappaB signal responsiveness in human cells. Mol Cell Biol (1998) 0.89
In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity. Leukemia (2001) 0.88
Analytical approaches for MCPD esters and glycidyl esters in food and biological samples: a review and future perspectives. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2012) 0.86
Activation of pyridoxal kinase by metallothionein. Biochim Biophys Acta (1989) 0.85
Interaction and functional interference of C/EBPbeta with octamer factors in immunoglobulin gene transcription. Eur J Immunol (2000) 0.84
The role of oxygen metabolism for the pathological phenotype of Fanconi anemia. Hum Genet (1997) 0.82
Auditory cortex stimulation by low-frequency tones-an fMRI study. Brain Res (2009) 0.82
Efficient transcription of an immunoglobulin kappa promoter requires specific sequence elements overlapping with and downstream of the transcriptional start site. Nucleic Acids Res (1997) 0.81
Affinity labeling of pyridoxal kinase with adenosine polyphosphopyridoxal. J Biol Chem (1988) 0.80
Activation of a histone H1 kinase by tyrosine phosphorylation in v-src-transformed fibroblasts. EMBO J (1993) 0.80
c-fos mRNA expression in rat cortical neurons during glutamate-mediated excitotoxicity. Toxicol Sci (2004) 0.80
Diagnosis of endolymphatic hydrops by low-frequency masking. Audiol Neurootol (1997) 0.80
Modulation of the catalytic activity of the Src family tyrosine kinase Hck by autophosphorylation at a novel site in the unique domain. J Biol Chem (2000) 0.79
Effect of calcitonin and 1,25(OH)2-vitamin D3 on the FSH, LH and testosterone secretion at rest and LHRH stimulated secretion. Horm Metab Res (1989) 0.79
Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect. Toxicol Appl Pharmacol (2010) 0.79
New crystalline aluminum alkoxide oxide fluorides: evidence of the mechanism of the fluorolytic sol-gel reaction. Dalton Trans (2011) 0.78
Electrophoretic patterns of spermatozoal nucleoproteins (NP) in fertile men and infertility patients and comparison with NP of somatic cells. Andrologia (1990) 0.78
Toxicogenomic analysis of N-nitrosomorpholine induced changes in rat liver: comparison of genomic and proteomic responses and anchoring to histopathological parameters. Toxicol Appl Pharmacol (2009) 0.78
Transcription factors: important tools and targets for molecular medicine. J Mol Med (Berl) (1996) 0.78
Metabolism of pyridine nucleotides and its relation to DNA synthesis in regenerating mouse liver. Hoppe Seylers Z Physiol Chem (1972) 0.77
Low-frequency distortion product otoacoustic emission test compared to ECoG in diagnosing endolymphatic hydrops. Eur Arch Otorhinolaryngol (2008) 0.77
[Diagnosis of endolymphatic hydrops with low tone masked otoacoustic emissions]. Laryngorhinootologie (1995) 0.77
Preliminary results of the ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim (2001) 0.77
Modulation of the catalytic activity of pyridoxal kinase by metallothionein. Biochem Int (1988) 0.76
Neither the endogenous nor a functional steroid hormone receptor binding site transactivate the ribosomal RNA gene promoter in vitro. J Steroid Biochem Mol Biol (1991) 0.76
Generation and characterization of monoclonal antibodies to the Src-family kinase Hck. Hybridoma (2000) 0.76
Cutaneous inflammation and proliferation in vitro: differential effects and mode of action of topical glucocorticoids. Skin Pharmacol Appl Skin Physiol (2000) 0.76
Brain pyridoxal kinase dissociation of the dimeric structure and catalytic activity of the monomeric species. Eur J Biochem (1987) 0.76
Risk-benefit considerations of mitigation measures on acrylamide content of foods--a case study on potatoes, cereals and coffee. Br J Nutr (2008) 0.76
[From horse shoeing to hoof orthopedia (author's transl)]. Dtsch Tierarztl Wochenschr (1981) 0.75
[Isolation of various active principles from Cardaria draba (L.) Desv.; degradation products of sulforaphan]. Cesk Farm (1977) 0.75
[Effects of flurazepam on disturbed sleep in patients with AIDS]. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb (1989) 0.75
[Evaluation of contact and care centers, a low-threshold daytime source in the city of Zurich]. Soz Praventivmed (1996) 0.75
On the molecular basis of pyruvate kinase deficiency. Biochim Biophys Acta (1974) 0.75
[Visual motor coordination of AIDS patients, HIV-positive asymptomatic probands and healthy persons during video-tracking]. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb (1989) 0.75
Crystallization and preliminary X-ray studies of pyridoxal kinase from sheep brain. J Biol Chem (1989) 0.75
[Early and late prognosis concerning children of the diabetic mothers]. Padiatr Grenzgeb (1970) 0.75
Low-molecular-weight polypeptides of vicilin from Vicia faba L. are products of proteolytic breakdown. Eur J Biochem (1983) 0.75
[Functional variations in the permeability of the plasma membrane of sperm for ethidium bromide]. Arch Exp Veterinarmed (1986) 0.75
[Hodgkin's sarcoma in immunosuppressive treated erythematosus visceralis]. Verh Dtsch Ges Inn Med (1973) 0.75
[Electron microscopic-autoradiographic observations on the distribution of 9,10-dimethyl-1,2-benzanthracene in Ehrlich ascites cells after partial lipid extraction]. Arch Geschwulstforsch (1970) 0.75
Masking and pitch shift of tone bursts and clicks by low-frequency tones. Hear Res (1995) 0.75
[Seed globulins from legumes. III. Seed globulins from broad bean (Vicia faba L.)]. Nahrung (1975) 0.75
[A system for continuous digitizing and evaluation of 32 biosignals from all-night sleep leads]. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb (1989) 0.75
[Spectral power density and coherence in sleep EEG in patients with acquired immunodeficiency syndrome]. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb (1989) 0.75
[Studies in pregnancy detection in the swine by hormone application under practical circumstances]. Tierarztl Umsch (1974) 0.75
[Degradation behavior of pesticides in porous groundwater conductors]. Schriftenr Ver Wasser Boden Lufthyg (1989) 0.75
[Electrolyte balance in major abdominal surgery. II. Observations under combined general and regional anaesthesia versus enflurane anaesthesia (author's transl)]. Anaesthesist (1977) 0.75